Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | FDPS | P14324 | 3/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | LCK | P06239 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.38 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.38 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26156039 | 1.00 | TSHR (0.44) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL27563773 | 1.00 | TSHR (0.44) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL1123306 | 1.00 | TSHR (0.44) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL1123635 | 1.00 | TSHR (0.44) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL11042203 | 1.00 | TSHR (0.44) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL9732346 | 1.00 | TSHR (0.44) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL4572540 | 1.00 | TSHR (0.44) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL10959492 | 1.00 | TSHR (0.44) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL1123381 | 1.00 | TSHR (0.44) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL1901863 | 1.00 | TSHR (0.44) | TSHRTHRBLMNADNM1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3340283-B1 | WAFER WASHING METHOD, AND LIQUID CHEMICAL USED IN SAME | CENTRAL GLASS CO LTD (JP) | 2020-05-20 | — | — | EP | claimed |
| CN-109776759-A | A kind of high temperature resistant scratch resistance can stamp hide umbrella cloth surface layer polyurethane resin, preparation process and its application entirely | 南通紫琅生物医药科技有限公司 | 2019-05-21 | — | — | CN | claimed |
| EP-4638015-A1 | SULFUR COMPOSITIONS FOR FROTH FLOTATION OF ORES | Arkema, Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| EP-3527600-B1 | ISOCYANATE COMPOSITION AND PRODUCTION METHOD FOR ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-09 | — | — | EP | disclosed |
| US-12241010-B2 | Perovskite color converter and method of manufacturing the same | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-03-04 | — | — | US | disclosed |
| US-12181834-B2 | Electrostatic image developing toner set and electrostatic image developer set | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2024-12-31 | — | — | US | disclosed |
| WO-2024137153-A1 | SULFUR COMPOSITIONS FOR FROTH FLOTATION OF ORES | ARKEMA INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| US-20230322834-A1 | POLYMERIZATION AND FUNCTIONALIZATION OF LEVOGLUCOSAN DERIVATIVES | NATIONAL SCIENCE FOUNDATION | 2023-10-12 | — | — | US | disclosed |
| CN-109557778-B | Toner and toner set | 富士胶片商业创新有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-112979917-B | Isocyanate composition, method for producing isocyanate composition, and method for producing isocyanate polymer | 旭化成株式会社 | 2023-04-25 | — | — | CN | disclosed |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-04-13 | — | — | US | disclosed |
| WO-1986006983-A1 | NOVEL COLLECTORS FOR THE SELECTIVE FROTH FLOTATION OF SULFIDE MINERALS | THE DOW CHEMICAL COMPANY (US) | 1986-12-04 | — | — | WO | disclosed |
| EP-0180266-A1 | Alkoxylation process using bimetallic oxo catalyst | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1986-05-07 | — | — | EP | disclosed |
| EP-0180267-A1 | Alkoxylation process using bimetallic oxo catalyst | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1986-05-07 | — | — | EP | disclosed |
| US-4575569-A | Alkoxylation of thiols in the presence of a reaction promoter | SHELL OIL COMPANY (US) | 1986-03-11 | — | — | US | disclosed |
| US-4563302-A | Sulfurized olefin process | EDWIN COOPER, INC. (US) | 1986-01-07 | — | — | US | disclosed |
| US-4439314-A | DODECYLMERCAPTAN, SODIUM ISOPROPYLXANTHATE, AND A POLYALKYLENE GLYCOL | PHILLIPS PETROLEUM COMPANY (US) | 1984-03-27 | — | — | US | disclosed |
| US-4351945-A | Two-phase process for the preparation of azole and azoline disulfides | EXXON RESEARCH & ENGINEERING CO. (US) | 1982-09-28 | — | — | US | disclosed |
| EP-0037985-A1 | Photographic material and compounds for use therein, and that release a photographically active moiety | Agfa-Gevaert AG (DE) | 1981-10-21 | — | — | EP | disclosed |
| EP-0038076-A1 | Method for removing iron impurities from glass-making sand | PHILLIPS PETROLEUM COMPANY (US) | 1981-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322834-A1 | POLYMERIZATION AND FUNCTIONALIZATION OF LEVOGLUCOSAN DERIVATIVES | ALG1, PGLS, DDOST | TSHR 3079/4885THRB 3438/4885LMNA 2289/4885 |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | IDH3A, IDH2, IDH3B | TSHR 4885/4885THRB 4879/4885LMNA 1933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.